Home › Funds › O'SHAUGHNESSY ASSET MANAGEMENT, LLC › GILD

O'SHAUGHNESSY ASSET MANAGEMENT, LLC position in GILD

GILEAD SCIENCES INC · Health Care

O'SHAUGHNESSY ASSET MANAGEMENT, LLC reported holding 607,262 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$106.0M, representing 0.64% of its reported portfolio and ranking #19 among its reported holdings. O'SHAUGHNESSY ASSET MANAGEMENT, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)607.26K sh
Reported value held$105.96M
Portfolio Weight0.64%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How O'SHAUGHNESSY ASSET MANAGEMENT, LLC's GILD position evolved

O'SHAUGHNESSY ASSET MANAGEMENT, LLC first disclosed a stake in GILD in Q3 2023 at 220,849 shares (US$16.6M). The position peaked in Q3 2026 at 607,262 shares, worth US$106.0M. Across 13 filings, O'SHAUGHNESSY ASSET MANAGEMENT, LLC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 607,262 shares valued at US$106.0M — an increase of 42,652 shares quarter over quarter.. Notable position changes include a 36% increase in Q3 2024 (shares rose 11% over the following quarter), a 53% increase in Q4 2024 (shares rose 21% over the following quarter), a 31% increase in Q1 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 220.85K $16.55M New
Q4 2023 223.35K $18.09M Add
Q1 2024 218.55K $16.01M Reduce
Q2 2024 152.25K $10.45M Reduce
Q3 2024 207.25K $17.63M Add
Q4 2024 317.30K $29.31M Add
Q1 2025 415.91K $46.60M Add
Q2 2025 495.55K $54.94M Add
Q3 2025 557.51K $61.88M Add
Q4 2025 607.08K $74.51M Add
Q1 2026 645.23K $89.93M Add
Q2 2026 564.61K $71.33M Reduce
Q3 2026 607.26K $105.96M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has O'SHAUGHNESSY ASSET MANAGEMENT, LLC held GILD?

O'SHAUGHNESSY ASSET MANAGEMENT, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is O'SHAUGHNESSY ASSET MANAGEMENT, LLC's current position in GILD?

As of Q3 2026, O'SHAUGHNESSY ASSET MANAGEMENT, LLC holds 607.26K shares of GILD (GILEAD SCIENCES INC), valued at $105.96M, representing 0.64% of its reported portfolio and ranking #19.

Has O'SHAUGHNESSY ASSET MANAGEMENT, LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), O'SHAUGHNESSY ASSET MANAGEMENT, LLC increased its position in GILD. The position peaked in Q3 2026 at 607.26K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.